2021 ESC/EACTS Guidelines for management of valvular heart disease- Aortic stenosis
Medical Dialogues interacts with Dr O P Yadava, a Cardiothoracic surgeon who has given his expert insights on the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery guidelines. Aortic stenosis (AS) is a common valvular heart disease, with an estimated overall prevalence of 3% in adults over 75 years. Aortic stenosis is the most frequent, single,...
Medical Dialogues interacts with Dr O P Yadava, a Cardiothoracic surgeon who has given his expert insights on the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery guidelines.
Aortic stenosis (AS) is a common valvular heart disease, with an estimated overall prevalence of 3% in adults over 75 years. Aortic stenosis is the most frequent, single, native left-sided valve disease comprising of 43%. Aortic stenosis is the most common primary valve lesion requiring surgery or transcatheter intervention and its prevalence is rising rapidly as a consequence of the ageing population.
Now, the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery guidelines have covered the evaluation parameters, the diagnostic workup involved, the indications for intervention- be it either TAVI or the Surgical AVR procedure and about the medical therapy.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd